Home › Mesothelioma › New York
Mesothelioma clinical trials in New York
11 studies for Mesothelioma are looking for participants at sites in New York.
Cities in New York
- New York City10 studies
- Queens4 studies
- Staten Island3 studies
- Greenburgh3 studies
- New Rochelle3 studies
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Columbia University Irving Medical Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07277413Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- NYU Langone Medical Center, New York
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT04981119A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
- Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activites), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06057935Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent Only), Commack
- Memorial Sloan Kettering Westchester (Consent Only), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- and 1 more
Recruiting
Ages 30 to 85 · All sexes · Updated Sep 24, 2026 · NCT06037941Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- New York University Langone Health, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05732831Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
- Perlmutter Cancer Center at NYU Langone Hospital Long Island, Mineola
- David H Koch, Memorial Sloan Kettering Cancer Center, New York
- New york cancer and blood specialists - Oncology, Port Jefferson Station
- and 1 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT05245500Integrated Cancer Repository for Cancer Research
- C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
- Faxton St. Luke's Healthcare, Mohawk Valley, Utica
RecruitingObservational studyHealthy volunteers welcome
Ages 19 to 110 · All sexes · Updated Jun 29, 2026 · NCT02012699A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- NYU Langone Medical Center, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 12, 2026 · NCT06051695A Study of Sacituzumab Govitecan in People With Mesothelioma
- Memorial Sloan Kettering Cancer Center @ Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan - Kettering Cancer Center, New York
- and 1 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 28, 2026 · NCT06477419Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 2, 2026 · NCT04665206VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Weill Cornell Medicine, Cornell University (site 126), New York
RecruitingPhase 1/2
Ages 18 to 80 · All sexes · Updated Dec 11, 2025 · NCT03556228From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.